JFS WEALTH ADVISORS, LLC - AGIOS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
JFS WEALTH ADVISORS, LLC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$174
+2.4%
7
+16.7%
0.00%
Q2 2023$170
+23.2%
60.0%0.00%
Q1 2023$138
-38.7%
6
-25.0%
0.00%
Q4 2022$22580.0%0.00%
Q3 2022$08
+100.0%
0.00%
Q2 2022$04
-33.3%
0.00%
Q1 2022$06
+200.0%
0.00%
Q4 2021$020.00%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
BB BIOTECH AG 2,719,998$155,502,0004.38%
Casdin Capital, LLC 295,000$16,865,0004.11%
Opaleye Management Inc. 130,000$7,432,0002.38%
Opus Point Partners Management, LLC 28,704$1,641,0001.42%
Fernwood Investment Management, LLC 27,550$1,575,0000.84%
Rhenman & Partners Asset Management AB 100,000$5,717,0000.77%
COLUMBIA WANGER ASSET MANAGEMENT LLC 760,116$43,456,0000.65%
Eventide Asset Management 214,000$12,234,0000.64%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 262,984$15,035,0000.59%
CAPITAL GUARDIAN TRUST CO 663,089$37,909,0000.54%
View complete list of AGIOS PHARMACEUTICALS INC shareholders